+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Adhesion Barrier Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5234117
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Adhesion Barrier Market is projected to reach USD 1.13 Billion in 2026. It is expected to continue growing at a CAGR of 7.45%, reaching USD 1.75 Billion by 2032.

Adhesion barriers are bioresorbable films, gels, liquids, and membranes used during surgery to reduce post-surgical adhesions, a frequent cause of chronic pain, infertility, bowel obstruction, and costly reoperations. Peer-reviewed surgical literature reports adhesions after a substantial share of abdominal and pelvic procedures, making adhesion prevention a measurable priority for gynecology, colorectal surgery, general surgery, urology, orthopedics, and cardiovascular applications.

The adhesion barrier market is being shaped by rising global surgical volumes, wider use of minimally invasive and robotic surgery, and demand for products that support faster recovery and lower complication-related spending. Evidence-backed adoption is strongest where hospitals can link barrier use to clinical protocols, surgeon training, reimbursement logic, and value-based outcomes.

Transformative Shifts in the Adhesion Barrier Landscape

The landscape is shifting from traditional sheet-based barriers toward site-specific, easy-to-apply gel, spray, and flowable formulations that fit laparoscopic and robotic workflows. Materials such as hyaluronic acid, carboxymethylcellulose, oxidized regenerated cellulose, polyethylene glycol, collagen, and other bioresorbable polymers remain central to product differentiation, with buyers prioritizing biocompatibility, handling, residence time, resorption profile, and clinical evidence.

Regulatory scrutiny is also changing market behavior. Hospitals and procurement bodies increasingly expect real-world outcomes, procedure-level evidence, sterility assurance, biocompatibility documentation, and safety data rather than broad claims. Manufacturers that align clinical studies with high-burden procedures, infection-control requirements, operating room efficiency, and surgeon usability are better positioned to win formulary access.

Cumulative Impact of Artificial Intelligence on Adhesion Prevention

Artificial intelligence is not replacing surgical judgment in adhesion prevention, but it is becoming a powerful enabler across the care pathway. AI-supported analytics can help identify patients at elevated risk based on prior surgeries, inflammatory conditions, procedure type, comorbidities, operative duration, conversion history, and previous adhesion-related complications, allowing hospitals to standardize when an adhesion barrier should be considered.

AI is also improving evidence generation. Claims analysis, electronic health record mining, computer vision in robotic surgery, natural language processing of operative notes, and real-world data platforms can support stronger post-market surveillance and comparative effectiveness research. Over time, these tools can help manufacturers refine product design, optimize placement guidance, strengthen surgeon training, and demonstrate economic value to payers and health systems.

Key Regional Insights for Adhesion Barriers

Asia-Pacific is a high-opportunity region due to large surgical volumes, hospital expansion, and rising investment in advanced operating rooms across China, India, Japan, South Korea, and Australia. Adoption varies widely, with mature markets emphasizing clinical evidence, surgeon familiarity, and product quality, while emerging markets balance cost sensitivity with the documented burden of repeat surgery, infertility care, bowel obstruction management, and post-operative complications.

North America remains one of the most evidence-driven regions, supported by advanced surgical infrastructure, stronger awareness of adhesion-related complications, established product availability, and purchasing decisions linked to clinical protocols and value-based care. Europe is shaped by Medical Device Regulation requirements, hospital tendering, clinical evaluation expectations, and surgeon preference for products with robust safety data. Latin America is led by Brazil and Mexico, where private hospital networks and specialist surgical centers are accelerating adoption. The Middle East, especially GCC health systems, is investing in premium surgical technologies and operating room modernization, while Africa shows long-term potential as access to essential surgery, specialist procedures, and hospital-based surgical quality programs expands.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are gaining relevance as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines expand surgical capacity, minimally invasive procedure access, and medical tourism, although reimbursement, formulary discipline, and procurement maturity differ by country. The GCC is characterized by centralized purchasing, premium hospital infrastructure, and strong demand for technologies that improve surgical quality, reduce downstream complications, and support specialist gynecology, colorectal, and general surgery programs.

The European Union prioritizes regulatory compliance, clinical documentation, post-market surveillance, and tender competitiveness under stricter device oversight. BRICS countries represent a major procedural-volume opportunity because of population scale, expanding healthcare access, and hospital modernization, but affordability, local distribution, and public procurement remain decisive. G7 markets continue to lead in innovation adoption, surgeon training, clinical evaluation, and post-market evidence generation, while NATO member countries indirectly support uptake through advanced hospital systems, standardized procurement practices, resilient surgical infrastructure, and investment in high-quality perioperative care.

Key Country Insights in the Adhesion Barrier Market

The United States leads in clinical adoption and innovation due to high procedure volumes, established medical technology commercialization, availability of advanced minimally invasive surgery, and a strong focus on reducing avoidable readmissions and reoperations. Canada emphasizes evidence-based procurement and hospital formulary review, while Mexico and Brazil are expanding use through private hospitals, tertiary care centers, and specialist surgical networks. In Europe, the United Kingdom, Germany, France, Italy, and Spain show steady demand, with Germany and France particularly influenced by clinical evaluation, reimbursement discipline, and hospital purchasing controls.

Russia remains a complex market shaped by localization priorities, public procurement constraints, and supply-chain considerations. China and India offer significant long-term potential due to large surgical volumes, hospital modernization, growing specialist capacity, and wider access to laparoscopic procedures, though price sensitivity and regional variation remain important. Japan values product quality, safety, regulatory rigor, and aging-population surgical needs, while Australia and South Korea benefit from advanced surgical infrastructure, strong specialist adoption, clinical guideline awareness, and growing use of minimally invasive and robotic procedures.

Actionable Recommendations for Adhesion Barrier Industry Leaders

Industry leaders should prioritize procedure-specific evidence in gynecology, colorectal, general, and urologic surgery, where adhesion-related complications are well documented. Commercial teams should support surgeons with clear placement protocols, laparoscopic usability data, compatibility guidance, and training that connects product handling with measurable clinical outcomes.

Manufacturers can strengthen market access by pairing clinical trials with real-world evidence, post-market surveillance, health economic models, and hospital budget impact analyses. Partnerships with robotic surgery programs, ambulatory surgery centers, academic hospitals, and integrated delivery networks can improve adoption. Companies should also design portfolios that address both premium and cost-sensitive markets without compromising biocompatibility, sterility, safety, resorption performance, or regulatory rigor.

Research Methodology

This executive summary is built from validated secondary research, including peer-reviewed surgical literature, medical device regulatory guidance, public health statistics, clinical practice trends, hospital procurement indicators, and published evidence on adhesion-related complications. Evidence was assessed for relevance to adhesion prevention, surgical workflow, material science, geographic adoption, regulatory expectations, and health economic impact.

The research approach combines top-down analysis of surgical demand, disease burden, and regulatory drivers with bottom-up review of product categories, end-use procedures, clinical evidence, and regional adoption patterns. Insights are triangulated across clinical literature, market behavior, regulatory context, and expert interpretation to provide data-grounded view of the adhesion barrier market.

Conclusion

The adhesion barrier market is evolving from a product-focused category into a broader surgical value proposition centered on complication reduction, operating room efficiency, and evidence-based recovery. Demand is supported by the persistent clinical burden of post-surgical adhesions and by the need for practical solutions compatible with open, laparoscopic, and robotic surgical techniques.

Future growth will favor manufacturers that combine proven biomaterials, strong clinical documentation, intuitive application, and real-world outcome data. As AI, minimally invasive surgery, robotic procedures, and value-based procurement mature, adhesion prevention will become increasingly integrated into standardized surgical quality programs worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Reframe adhesion prevention as surgical complication economics
4.3.1.2. Align product format with laparoscopic and robotic workflows
4.3.1.3. Use regulatory rigor as a premium-market access advantage
4.3.1.4. Target high-risk patient cohorts created by demographic and disease burden
4.3.2. Key Restraints
4.3.2.1. Resolve evidence gaps that weaken reimbursement and standardization
4.3.2.2. Protect margins under procurement and tariff pressure
4.3.3. Key Opportunities
4.3.3.1. Commercialize robotic-compatible delivery platforms
4.3.3.2. Build premium niches around spine and intrauterine indications
4.3.3.3. Scale value-priced gels through emerging-market distribution
4.3.4. Key Challenges
4.3.4.1. Convert fragmented clinical endpoints into procurement-grade evidence
4.3.4.2. Build geopolitical resilience into sterile device supply chains
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Adhesion Barrier Market, by Product Type
7.1. Introduction
7.2. Film
7.3. Gel
7.3.1. Hyaluronic Acid Gels
7.3.2. Polyethylene Glycol Gels
7.4. Liquid
7.4.1. Sprayable Solutions
7.4.2. Irrigation Solutions
7.5. Membrane
8. Adhesion Barrier Market, by Material Type
8.1. Introduction
8.2. Natural Polymers
8.3. Synthetic Polymers
9. Adhesion Barrier Market, by Formulation Type
9.1. Introduction
9.2. Absorbable
9.2.1. Short Term Absorption
9.2.2. Long Term Absorption
9.3. Non-Absorbable
9.3.1. Permanent Barrier
9.3.2. Removal-Required Barrier
10. Adhesion Barrier Market, by Surgery Type
10.1. Introduction
10.2. Open Surgery
10.3. Minimally Invasive Surgery
10.3.1. Laparoscopic Surgery
10.3.2. Robotic-Assisted Surgery
11. Adhesion Barrier Market, by Application
11.1. Introduction
11.2. Gynecological Surgery
11.2.1. Myomectomy
11.2.2. Endometriosis Surgery
11.3. Abdominal Surgery
11.3.1. Colorectal Surgery
11.3.2. Hepatobiliary Surgery
11.4. Orthopedic Surgery
11.4.1. Tendon Repair
11.4.2. Joint Reconstruction
11.5. Cardiovascular Surgery
11.6. Neurological Surgery
11.6.1. Cranial Surgery
11.6.2. Spinal Surgery
12. Adhesion Barrier Market, by Distribution Channel
12.1. Introduction
12.2. Online
12.2.1. eCommerce Platform
12.2.2. Manufacturer Website
12.3. Offline
13. Adhesion Barrier Market, by Region
13.1. Europe
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Middle East
13.6. Africa
14. Adhesion Barrier Market, by Group
14.1. NATO
14.2. G7
14.3. European Union
14.4. BRICS
14.5. ASEAN
14.6. GCC
15. Adhesion Barrier Market, by Country
15.1. United States
15.2. China
15.3. Germany
15.4. Japan
15.5. India
15.6. United Kingdom
15.7. Brazil
15.8. France
15.9. Canada
15.10. Italy
15.11. South Korea
15.12. Mexico
15.13. Spain
15.14. Australia
15.15. Russia
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
List of Figures
FIGURE 1. GLOBAL ADHESION BARRIER MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ADHESION BARRIER MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ADHESION BARRIER MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ADHESION BARRIER MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ADHESION BARRIER MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ADHESION BARRIER MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ADHESION BARRIER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL ADHESION BARRIER MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ADHESION BARRIER MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ADHESION BARRIER MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL FILM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL FILM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL FILM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL GEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL GEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL HYALURONIC ACID GELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL HYALURONIC ACID GELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL HYALURONIC ACID GELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL POLYETHYLENE GLYCOL GELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL POLYETHYLENE GLYCOL GELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL POLYETHYLENE GLYCOL GELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SPRAYABLE SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SPRAYABLE SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SPRAYABLE SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL IRRIGATION SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL IRRIGATION SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL IRRIGATION SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MEMBRANE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL MEMBRANE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MEMBRANE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL NATURAL POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL NATURAL POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL NATURAL POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC POLYMERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ABSORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ABSORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ABSORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SHORT TERM ABSORPTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SHORT TERM ABSORPTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SHORT TERM ABSORPTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL LONG TERM ABSORPTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL LONG TERM ABSORPTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL LONG TERM ABSORPTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL NON-ABSORBABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NON-ABSORBABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NON-ABSORBABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PERMANENT BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PERMANENT BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PERMANENT BARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL REMOVAL-REQUIRED BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL REMOVAL-REQUIRED BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL REMOVAL-REQUIRED BARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL LAPAROSCOPIC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL LAPAROSCOPIC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL LAPAROSCOPIC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ROBOTIC-ASSISTED SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ROBOTIC-ASSISTED SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ROBOTIC-ASSISTED SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL GYNECOLOGICAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL MYOMECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MYOMECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MYOMECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOMETRIOSIS SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ENDOMETRIOSIS SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ENDOMETRIOSIS SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ABDOMINAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL COLORECTAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL COLORECTAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL COLORECTAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HEPATOBILIARY SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HEPATOBILIARY SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HEPATOBILIARY SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ORTHOPEDIC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL TENDON REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL TENDON REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TENDON REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL NEUROLOGICAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL NEUROLOGICAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL NEUROLOGICAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CRANIAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CRANIAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL CRANIAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL SPINAL SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL SPINAL SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SPINAL SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ECOMMERCE PLATFORM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ECOMMERCE PLATFORM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ECOMMERCE PLATFORM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL MANUFACTURER WEBSITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL MANUFACTURER WEBSITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL MANUFACTURER WEBSITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. EUROPE ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. EUROPE ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 123. EUROPE ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 124. EUROPE ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 125. EUROPE ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 126. EUROPE ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 127. EUROPE ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 128. EUROPE ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 129. EUROPE ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 130. EUROPE ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 131. EUROPE ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 132. EUROPE ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 133. EUROPE ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 134. EUROPE ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 135. EUROPE ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 136. EUROPE ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 137. EUROPE ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 189. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 206. AFRICA ADHESION BARRIER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 207. AFRICA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. AFRICA ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 209. AFRICA ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 210. AFRICA ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 211. AFRICA ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 212. AFRICA ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 213. AFRICA ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 214. AFRICA ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 215. AFRICA ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 216. AFRICA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. AFRICA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 218. AFRICA ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 219. AFRICA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 220. AFRICA ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 221. AFRICA ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 222. AFRICA ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. NATO ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 225. NATO ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 226. NATO ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 227. NATO ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 228. NATO ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 229. NATO ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 230. NATO ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 231. NATO ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 232. NATO ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 233. NATO ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 234. NATO ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. NATO ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 236. NATO ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 237. NATO ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 238. NATO ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 239. NATO ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 240. NATO ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 241. G7 ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. G7 ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 243. G7 ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 244. G7 ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 245. G7 ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 246. G7 ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 247. G7 ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 248. G7 ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 249. G7 ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 250. G7 ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 251. G7 ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. G7 ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 253. G7 ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 254. G7 ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 255. G7 ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 256. G7 ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. G7 ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 275. BRICS ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. BRICS ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. BRICS ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 278. BRICS ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 279. BRICS ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 280. BRICS ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 281. BRICS ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 282. BRICS ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 283. BRICS ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 284. BRICS ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 285. BRICS ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. BRICS ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 287. BRICS ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 288. BRICS ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 289. BRICS ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 290. BRICS ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 291. BRICS ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 292. ASEAN ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 293. ASEAN ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 294. ASEAN ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 295. ASEAN ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 296. ASEAN ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 297. ASEAN ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 298. ASEAN ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 299. ASEAN ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 300. ASEAN ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 301. ASEAN ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 302. ASEAN ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 303. ASEAN ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 304. ASEAN ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 305. ASEAN ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 306. ASEAN ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 307. ASEAN ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 308. ASEAN ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 309. GCC ADHESION BARRIER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 310. GCC ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 311. GCC ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 312. GCC ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 313. GCC ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 314. GCC ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 315. GCC ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 316. GCC ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 317. GCC ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 318. GCC ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 319. GCC ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. GCC ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 321. GCC ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 322. GCC ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 323. GCC ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 324. GCC ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 325. GCC ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 326. GLOBAL ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES ADHESION BARRIER MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 336. UNITED STATES ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 337. UNITED STATES ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 338. UNITED STATES ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 339. UNITED STATES ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 340. UNITED STATES ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 341. UNITED STATES ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 342. UNITED STATES ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 343. UNITED STATES ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 344. CHINA ADHESION BARRIER MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. CHINA ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 346. CHINA ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 347. CHINA ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 348. CHINA ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 349. CHINA ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 350. CHINA ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 351. CHINA ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 352. CHINA ADHESION BARRIER MARKET SIZE, BY SURGERY TYPE, 2017-2032 (USD MILLION)
TABLE 353. CHINA ADHESION BARRIER MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, 2017-2032 (USD MILLION)
TABLE 354. CHINA ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 355. CHINA ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 356. CHINA ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERY, 2017-2032 (USD MILLION)
TABLE 357. CHINA ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2017-2032 (USD MILLION)
TABLE 358. CHINA ADHESION BARRIER MARKET SIZE, BY NEUROLOGICAL SURGERY, 2017-2032 (USD MILLION)
TABLE 359. CHINA ADHESION BARRIER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 360. CHINA ADHESION BARRIER MARKET SIZE, BY ONLINE, 2017-2032 (USD MILLION)
TABLE 361. GERMANY ADHESION BARRIER MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 362. GERMANY ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 363. GERMANY ADHESION BARRIER MARKET SIZE, BY GEL, 2017-2032 (USD MILLION)
TABLE 364. GERMANY ADHESION BARRIER MARKET SIZE, BY LIQUID, 2017-2032 (USD MILLION)
TABLE 365. GERMANY ADHESION BARRIER MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 366. GERMANY ADHESION BARRIER MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 367. GERMANY ADHESION BARRIER MARKET SIZE, BY ABSORBABLE, 2017-2032 (USD MILLION)
TABLE 368. GERMANY ADHESION BARRIER MARKET SIZE, BY NON-ABSORBABLE, 2017-

Companies Mentioned

  • Baxter International Inc.
  • Johnson & Johnson Services, Inc.
  • Smith & Nephew PLC
  • Integra LifeSciences Corporation
  • Becton, Dickinson and Company
  • Terumo Corporation
  • CG Bio Inc.
  • Medtronic plc
  • Hangzhou Singclean Medical Products Co., Ltd.
  • Gunze Limited
  • W. L. Gore & Associates, Inc.
  • Luna Innovations Incorporated
  • AlloSource, Inc.
  • Betatech Medical Ltd.
  • Bioscompass, Inc.
  • CHA Meditech Co., Ltd.
  • CorMatrix Cardiovascular, Inc.
  • FzioMed, Inc.
  • MAST Biosurgery AG
  • PlantTec Medical GmbH
  • Seikagaku Corporation
  • Semical GmbH
  • Womed SAS

Table Information